Clinical Trial Update: Effects of Nitric Oxide and Nitroglycerin in Patients With Sickle Cell Anemia [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the effects of nitric oxide and nitroglycerin in patients with sickle cell anemia; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Drugs mentioned

• NITROGLYCERIN (Nitroglycerin)
• Nitric Oxide (nitric oxide)

Snippet

Sponsor: National Institutes of Health Clinical Center (CC) | Conditions: Chest Pain, Sickle Cell Anemia | Phase 2 | Status: COMPLETED